CD99SF engagement by antibodies in breast cancer increased the expression of JunD and FosB AP-1 factors, along with the activation of PI3K-Akt signaling pathway by phosphorylation of Src, Akt, p38 MAPK, ERK and JNK [31]. Here, JUNB is linked to breast cancer.